GILEAD SCIENCES, INC. — Director's Dealing 2016

Jun 2, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2016-05-31

Reporting Person: Carter Paul Rutherford (EVP Commercial Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-31	Common Stock	M	43200	$24.295	Acquired	104322	Direct
2016-05-31	Common Stock	M	4232	$24.905	Acquired	108554	Direct
2016-05-31	Common Stock	M	5795	$80.65	Acquired	114349	Direct
2016-05-31	Common Stock	M	3865	$80.65	Acquired	118214	Direct
2016-05-31	Common Stock	S	57092	$86.8528	Disposed	61122	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-31	Non-qualified Stock Option (Right to Buy)	$24.295	M	43200	Disposed	2022-01-26	Common Stock (43200)	Direct
2016-05-31	Non-qualified Stock Option (Right to Buy)	$24.905	M	4232	Disposed	2019-07-29	Common Stock (4232)	Direct
2016-05-31	Non-qualified Stock Option (Right to Buy)	$80.65	M	5795	Disposed	2024-02-01	Common Stock (5795)	Direct
2016-05-31	Non-qualified Stock Option (Right to Buy)	$80.65	M	3865	Disposed	2024-02-01	Common Stock (3865)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

F3: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F4: Sale prices reported for the transactions reported here range from $86.6075 to $87.1008. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.